Elevance Health Market Sentiment

Elevance Health Inc

ELVNYSE

Trade with Public

$445.28

11.152.57%

Últ. Act.: Oct 22, 4:08 PM

$445.28

11.152.57%

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Dividendos Comparar Opciones Informe de acciones

PRO

¿Por qué se mueve?:Elevance Health shares are trading lower despite reporting better-than-expe...

Ganancias: Los beneficios de Q3 2026 se publicaron el mié oct 21st, antes de la apertura del mercado

Conferencia telefónica: La conferencia telefónica más reciente comenzó a las 8:30 a. m., hace 1 día

Haz clic para ver el webcast

Elevance Health Market Sentiment - Benzinga

Elevance Health Market Sentiment

Market sentiment signals for Elevance Health (ELV): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.5% short float

Options Flow▼ 1.38 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

21 analysts

Options Flow (P/C)

1.38

More puts — Bearish

383 calls · 528 puts

Avg Consensus PT

$448

+0.5%

Highest Price Target

$523

+17.5%

UBS

Lowest Price Target

$343

-23.0%

Goldman Sachs

Short Interest

2.5%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 22, 2026	UBS	A.J. Rice—	+17.5%	$460 → $523	Maintained	Buy
Oct 22, 2026	Guggenheim	Jason Cassorla—	+8.9%	$460 → $485	Maintained	Buy
Oct 22, 2026	Morgan Stanley	Erin Wright—	+0.8%	$404 → $449	Maintained	Equal-Weight
Oct 22, 2026	RBC Capital	Ben Hendrix—	+2.2%	$424 → $455	Maintained	Sector Perform
Oct 22, 2026	Barclays	Andrew Mok—	+6.0%	$469 → $472	Maintained	Overweight
Oct 22, 2026	Baird	Michael Ha—	-8.8%	$393 → $406	Maintained	Neutral
Oct 12, 2026	Guggenheim	Jason Cassorla—	+3.3%	$455 → $460	Maintained	Buy
Oct 7, 2026	Barclays	Andrew Mok—	+5.3%	$457 → $469	Maintained	Overweight
Jul 17, 2026	Bernstein	Lance Wilkes—	+9.6%	$482 → $488	Maintained	Outperform
Jul 17, 2026	Leerink Partners	Whit Mayo—	-11.3%	$364 → $395	Maintained	Market Perform
Jul 16, 2026	RBC Capital	Ben Hendrix—	-4.8%	$439 → $424	Maintained	Sector Perform
Jul 16, 2026	Wells Fargo	Stephen Baxter—	+6.2%	$492 → $473	Maintained	Overweight
Jul 16, 2026	Guggenheim	Jason Cassorla—	+2.2%	$399 → $455	Maintained	Buy
Jul 16, 2026	Barclays	Andrew Mok—	+2.6%	$480 → $457	Maintained	Overweight
Jul 16, 2026	Baird	Michael Ha—	-11.7%	$331 → $393	Maintained	Neutral
Jul 14, 2026	TD Cowen	Ryan Langston—	+4.4%	$400 → $465	Maintained	Buy
Jul 14, 2026	Truist Securities	David Macdonald—	+6.7%	$450 → $475	Maintained	Buy
Jul 13, 2026	Wells Fargo	Stephen Baxter—	+10.5%	$391 → $492	Maintained	Overweight
Jul 9, 2026	RBC Capital	Ben Hendrix—	-1.4%	$358 → $439	Maintained	Sector Perform
Jul 7, 2026	Cantor Fitzgerald	Sarah James—	+1.1%	$400 → $450	Maintained	Overweight
Jul 2, 2026	Bernstein	Lance Wilkes—	+8.2%	$424 → $482	Maintained	Outperform
Jun 8, 2026	Mizuho	Ann Hynes—	+4.4%	$435 → $465	Maintained	Outperform
Jun 8, 2026	JP Morgan	Lisa Gill—	+6.9%	$411 → $476	Maintained	Overweight
Jun 4, 2026	B of A Securities	Kevin Fischbeck—	+3.3%	$435 → $460	Maintained	Buy
Jun 4, 2026	Morgan Stanley	Erin Wright—	-9.3%	$352 → $404	Maintained	Equal-Weight